Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic and Predictive Role of Intrinsic Molecular Subtypes in BRCA-associated Breast Cancer

NCT07617025 is registered in ClinicalTrials.gov with Angela Toss as lead sponsor.

NCT NCT07617025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07617025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic and Predictive Role of Intrinsic Molecular Subtypes in BRCA-associated Breast Cancer
Lead sponsor
Angela Toss
Phase
Observational
Overall status
Recruiting
Start date
September 5, 2024
Completion date
December 31, 2026
Enrollment
100 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer